Inflammatory Bowel Disease
The IBD Clinical Trials Team conducts clinical trials of new drugs for patients with inflammatory bowel diseases, including Crohn’s Disease, Ulcerative Colitis and related conditions.
UPlift
A post-marketing study of UPadacitinib evaluating speed of onset and durability of effectiveness for patients with moderate to severe Crohn’s disease for 3 years in the real-world
Trial status:
Recruiting
Contact:
IBD Clinical Trials Team
A study looking at bowel healing for patients
Trial status:
Recruiting
Contact:
IBD Clinical Trials Team